<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK475801" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK475801/" /><meta name="ncbi_pagename" content="Christianson Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Christianson Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Christianson Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/01/11" /><meta name="citation_author" content="Eric M Morrow" /><meta name="citation_author" content="Matthew F Pescosolido" /><meta name="citation_pmid" content="29334451" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK475801/" /><meta name="citation_keywords" content="Sodium/hydrogen exchanger 6" /><meta name="citation_keywords" content="SLC9A6" /><meta name="citation_keywords" content="Christianson Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Christianson Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Eric M Morrow" /><meta name="DC.Contributor" content="Matthew F Pescosolido" /><meta name="DC.Date" content="2018/01/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK475801/" /><meta name="description" content="Christianson syndrome (referred to as CS in this GeneReview), an X-linked disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues." /><meta name="og:title" content="Christianson Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Christianson syndrome (referred to as CS in this GeneReview), an X-linked disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK475801/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/christianson/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK475801/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CDF72E041103100000000024700E6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK475801_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK475801_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/choroid/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cgd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK475801_"><span class="title" itemprop="name">Christianson Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Eric M Morrow</span>, MD, PhD and <span itemprop="author">Matthew F Pescosolido</span>, BA.</p><a data-jig="ncbitoggler" href="#__NBK475801_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK475801_ai__"><div class="contrib half_rhythm"><span itemprop="author">Eric M Morrow</span>, MD, PhD<div class="affiliation small">Developmental Disorders Genetics Research Program<br />Emma Pendleton Bradley Hospital<br />The Warren Alpert Medical School<br />Department of Molecular Biology, Cell Biology, and Biochemistry<br />Hassenfeld Child Health Innovation Institute<br />Brown University<br />Providence, Rhode Island<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.napsefil@worrome" class="oemail">gro.napsefil@worrome</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Matthew F Pescosolido</span>, BA<div class="affiliation small">Developmental Disorders Genetics Research Program<br />Emma Pendleton Bradley Hospital<br />The Warren Alpert Medical School<br />Brown University<br />Providence, Rhode Island<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nworb@odilosocsep_wehttam" class="oemail">ude.nworb@odilosocsep_wehttam</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 11, 2018</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="christianson.Summary" itemprop="description"><h2 id="_christianson_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Christianson syndrome (referred to as CS in this <i>GeneReview</i>), an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females range from asymptomatic to mild ID and/or behavioral issues.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CS is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC9A6</i> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> and in a female proband by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SLC9A6</i> pathogenic variant on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management of neurodevelopmental disorders, feeding difficulties, and seizures are per standard care.</p><p><i>Surveillance:</i> At the time of follow-up clinical examinations, the following are recommended:</p><ul><li class="half_rhythm"><div>Measurement of weight and height (and calculation of body mass index)</div></li><li class="half_rhythm"><div>Assessment for scoliosis/kyphoscoliosis</div></li><li class="half_rhythm"><div>Detailed history and related assessments in adolescents and young adults for evidence of possible loss of any of the following skills: feeding, fine/gross motor skills, ambulation, and use of words/sounds</div></li></ul></div><div><h4 class="inline">Genetic counseling.</h4><p>CS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The risk to sibs depends on the genetic status of the mother. Heterozygous (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) females have a 50% chance of transmitting the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy. Sons who inherit the pathogenic variant will have CS; daughters who inherit the pathogenic variant may be asymptomatic or have mild ID and/or behavioral issues. Males with CS are not known to reproduce. Once the <i>SLC9A6</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk female relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="christianson.Diagnosis"><h2 id="_christianson_Diagnosis_">Diagnosis</h2><div id="christianson.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Christianson syndrome (referred to as CS in this <i>GeneReview</i>) <b>should be suspected</b> in an individual with the following clinical manifestations observed in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>].</p><p><b>Clinical manifestations</b></p><ul><li class="half_rhythm"><div>Developmental delay / intellectual disability: usually severe to profound</div></li><li class="half_rhythm"><div>Absent to minimal language development</div></li><li class="half_rhythm"><div>Hyperkinesis</div></li><li class="half_rhythm"><div>Epilepsy: onset usually before age three years</div></li><li class="half_rhythm"><div>Truncal ataxia</div></li><li class="half_rhythm"><div>Postnatal-onset microcephaly</div></li><li class="half_rhythm"><div>Nondysmorphic facial features</div></li></ul></div><div id="christianson.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CS <b>is established</b> in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC9A6</i> and in a female proband by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SLC9A6</i> pathogenic variant on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK475801/table/christianson.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figchristiansonTmoleculargenetictesting" rid-ob="figobchristiansonTmoleculargenetictesting">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <a href="#christianson.GeneTargeted_Testing"><b>gene-targeted testing</b></a> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <a href="#christianson.Comprehensive_Genomic_Testi"><b>comprehensive genomic testing</b></a> (typically <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>).</p><div id="christianson.GeneTargeted_Testing"><h4>Gene-Targeted Testing</h4><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a href="#christianson.Comprehensive_Genomic_Testi">genomic testing</a> does not. Because the phenotypes of ID often overlap, most individuals with CS are diagnosed by either <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>. Single-gene testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SLC9A6</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> for intellectual disability, autism spectrum disorder, and/or epilepsy</b> that includes <i>SLC9A6</i> and other genes of interest (see <a href="#christianson.Differential_Diagnosis">Differential Diagnosis</a>) may be used. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Of note, given the rarity of Christianson syndrome, panels for ID may not include <i>SLC9A6</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK475801/table/christianson.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figchristiansonTmoleculargenetictesting" rid-ob="figobchristiansonTmoleculargenetictesting">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="christianson.Comprehensive_Genomic_Testi"><h4>Comprehensive Genomic Testing</h4><p>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (when clinically available) typically includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="christianson.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Christianson Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475801/table/christianson.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__christianson.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_christianson.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_christianson.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_christianson.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_christianson.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC9A6</i></td><td headers="hd_h_christianson.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_christianson.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29/32 (91%)&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_christianson.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_christianson.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/32 (9%)&#x000a0;<sup>5,&#x000a0;8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="christianson.TF.1.1"><p class="no_margin">See <a href="/books/NBK475801/#christianson.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="christianson.TF.1.2"><p class="no_margin">See <a href="#christianson.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="christianson.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="christianson.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a></p></div></dd><dt>5. </dt><dd><div id="christianson.TF.1.5"><p class="no_margin">Some probands were detected by screening large cohorts.</p></div></dd><dt>6. </dt><dd><div id="christianson.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al [1999]</a>, <a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al [2008]</a>, <a class="bk_pop" href="#christianson.REF.fichou.2009.1378">Fichou et al [2009]</a>, <a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al [2010]</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al [2010]</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al [2011]</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al [2013]</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al [2013]</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al [2014]</a>, <a class="bk_pop" href="#christianson.REF.zanni.2014.811">Zanni et al [2014]</a>, <a class="bk_pop" href="#christianson.REF.coorg.2015.527">Coorg &#x00026; Weisenberg [2015]</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al [2016]</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al [2016]</a>, <a class="bk_pop" href="#christianson.REF.trump.2016.310">Trump et al [2016]</a></p></div></dd><dt>7. </dt><dd><div id="christianson.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="christianson.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#christianson.REF.tzschach.2011.2771">Tzschach et al [2011]</a>, <a class="bk_pop" href="#christianson.REF.tzschach.2015.1513">Tzschach et al [2015]</a> (see <a href="#christianson.Molecular_Genetics">Molecular Genetics</a>, <b>Pathogenic variants</b>)</p></div></dd></dl></div></div></div></div></div></div><div id="christianson.Clinical_Characteristics"><h2 id="_christianson_Clinical_Characteristics_">Clinical Characteristics</h2><div id="christianson.Clinical_Description"><h3>Clinical Description</h3><p>Christianson syndrome (CS), an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder, typically manifests in males in the first few years of life with delayed developmental milestones and seizures. Additional findings in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males include intellectual disability (ID), absent to limited speech, postnatal microcephaly, truncal ataxia, hyperkinesis, and nondysmorphic facial features. Affected males may also manifest signs of autism spectrum disorder (ASD) and behaviors typically associated with <a href="/books/n/gene/angelman/">Angelman syndrome</a>. Of note, approximately one third of those with CS had received a prior clinical diagnosis of Angelman syndrome [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]. Other common problems include eye movement abnormalities, hypotonia, gastroesophageal reflux disease, feeding difficulties, and poor weight gain despite normal caloric intake. Regression (e.g., loss of ambulation and ability to feed independently) may occur.</p><p>The phenotypic spectrum in females <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> ranges from moderate ID, behavioral problems, and hyperactivity to asymptomatic.</p><div id="christianson.Affected_Males"><h4>Affected Males</h4><p><b>Common manifestations</b> (from <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al [2014]</a> and additional references where indicated):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Developmental delay and intellectual disability</b> typically range from moderate to profound, although mild ID has been reported [<a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>].</div><ul><li class="half_rhythm"><div>Gross motor milestones are delayed. Independent ambulation is achieved approximately one to two years later than average.</div></li><li class="half_rhythm"><div>Speech is generally absent. Very limited receptive language and use of a few single words may emerge in the first years of life; however, these words may subsequently be lost. To date, speech was unaffected in one adult male [<a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>].</div></li><li class="half_rhythm"><div>IQ is generally well below 35-40.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>ASD or autistic behaviors.</b> Notable findings include poor eye contact, lack of use of facial expressions to communicate, using bodies of others as a tool (e.g., to turn a doorknob), unusual sensory interests and preoccupations, and lack of reciprocal play / social interest [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.coorg.2015.527">Coorg &#x00026; Weisenberg 2015</a>]. In one cohort, 43% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males were previously diagnosed with ASD by a clinician [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]. The authors caution that diagnosis of ASD &#x02013; even with standardized assessments &#x02013; in nonverbal individuals with cognitive impairments may be challenging.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hyperkinesis.</b> Affected males are commonly described as having hyperkinesis (i.e., hyperactive and described by parents as "always on the go") [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.fichou.2009.1378">Fichou et al 2009</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Epilepsy.</b> Seizure onset is typically before age three years and is consistent with generalized epilepsy, although focal-onset seizures have been reported. Specific seizure types include infantile spasms, tonic, tonic-clonic, myoclonic, drop (unknown whether tonic or atonic), and absence seizures. Seizure frequency can range from daily clusters to seizure-free periods longer than one year.</div><div class="half_rhythm">EEG findings include abnormalities in both background (e.g., generalized slowing) and epileptiform activity (e.g., frequent generalized spike-wave complexes, irregular generalized spike-wave pattern, and multifocal independent and sometimes synchronous spikes). One individual had generalized discharges in more than 85% of slow-wave sleep recordings, a pattern associated with electrographic status epilepticus of sleep [<a class="bk_pop" href="#christianson.REF.coorg.2015.527">Coorg &#x00026; Weisenberg 2015</a>].</div><div class="half_rhythm">Clinical and EEG findings suggestive of Lennox-Gastaut syndrome, a <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> epileptic encephalopathy, have been reported [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>].</div><div class="half_rhythm">Epileptic encephalopathy (childhood-onset epilepsies characterized by severe, intractable, multiform seizures associated with cognitive impairments) has been reported [<a class="bk_pop" href="#christianson.REF.zanni.2014.811">Zanni et al 2014</a>]. Some suggest that epileptic encephalopathy appears in up to 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Truncal ataxia,</b> a nearly universal finding, is manifest in ambulatory males as an ataxic, unsteady gait. While ataxia is typically present with emergence of independent ambulation and is lifelong, late-onset worsening of ataxia at age 13 years [<a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>] and in the 40s-50s [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>] has been reported.</div><div class="half_rhythm">In one family, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boy and his maternal uncle did not have ataxia [<a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>].</div><div class="half_rhythm">Progressive cerebellar atrophy, particularly affecting the vermis, is one of the most common neuroimaging findings [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Postnatal microcephaly.</b> Head circumference is typically normal at birth. Microcephaly becomes evident over time.</div></li></ul><p><b>Distinctive features seen in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males</b> (from <a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al [1999]</a>, <a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al [2008]</a>, and <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al [2014]</a>, and additional references where indicated):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Abnormal eye movements,</b> such as convergent strabismus and esotropia, are common [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al 2013</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>]. Abnormal horizontal eye movements or the inability to look laterally, presumably due to dysfunction of cranial nerve VI and/or lateral recti muscles, are common [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Feeding difficulties.</b> Open mouth and drooling are common [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>]. Feeding difficulties can include sucking and swallowing problems in infancy as well as lack of coordination in chewing later in infancy. Gastroesophageal reflux disease may be present often requiring Nissen fundoplication surgery (see Management, <a href="#christianson.Treatment_of_Manifestations">Treatment of Manifestations</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Poor weight gain</b> occurs despite normal caloric intake. Low body mass index (BMI) becomes more pronounced with age. Older males have been described as appearing "emaciated."</div><div class="half_rhythm">Of note, birth weight (when reported) was normal in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Constipation</b> can be significant.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Regression,</b> typically beginning between ages 15 months and 16 years, can include loss of previously acquired skills such as independent ambulation, use of words/sounds, independent feeding, establishing eye contact / facial expressions, and fine/gross motor skills [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>].</div><div class="half_rhythm">Medical illness and/or severe or worsening seizure episodes usually precede regressions [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>].</div><div class="half_rhythm">The risk for regression appears to increase after the first decade of life as regression has been reported in males in their 40s-50s [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>].</div></li></ul><p><b>Findings identified in a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males</b> include the following:</p><ul><li class="half_rhythm"><div>Sleep disturbances, including frequent nighttime waking, an inability to fall asleep, and, in two males, no discernable sleep pattern [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>, <a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.mignot.2013.172">Mignot et al 2013</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]</div></li><li class="half_rhythm"><div>Scoliosis and one individual with severe kyphoscoliosis [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al 2013</a>]</div></li><li class="half_rhythm"><div>High pain threshold resulting in serious injury [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]</div></li><li class="half_rhythm"><div>Osteoporosis observed in some cases [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]</div></li></ul><p><b>Life expectancy.</b> Data on life expectancy are limited. Death in the second to fifth decade has been reported in a few individuals [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>]. Causes have included pyogenic bronchopneumonia superimposed on miliary tuberculosis [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>] and epileptic seizures [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>].</p><p><b>Pathology.</b> Postmortem brain examination in two adult males with CS from the same family showed diffuse glial tau deposition in cerebellar, brain stem, and centrum semiovale white matter tracts [<a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>]. In addition, tau-positive inclusions were found throughout the substantia nigra, <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> coeruleus, pontine nuclei, basal ganglia, thalamus, and cranial nerve nuclei.</p></div><div id="christianson.Heterozygous_Females_i_e_Ca"><h4>Heterozygous Females (i.e., Carriers)</h4><p>To date, 43 <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females in 17 families have been reported [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>, <a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.fichou.2009.1378">Fichou et al 2009</a>, <a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al 2013</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.zanni.2014.811">Zanni et al 2014</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al 2016</a>].</p><p>Manifestations range from no reported abnormal neurologic or psychological findings [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.fichou.2009.1378">Fichou et al 2009</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al 2013</a>] to mild or (rarely) moderate ID, behavioral issues, and hyperactivity [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>].</p><p>The most common findings:</p><ul><li class="half_rhythm"><div>Mild developmental delay (especially with speech/language) and/or mild intellectual disability [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.zanni.2014.811">Zanni et al 2014</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al 2016</a>]</div></li><li class="half_rhythm"><div>In some, a notable discrepancy on neuropsychological testing between verbal and performance IQ, with verbal IQ being much lower [<a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>]</div></li><li class="half_rhythm"><div>Speech disorder/dysphasia [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al 2016</a>]</div></li><li class="half_rhythm"><div>Dyslexia [<a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>]</div></li><li class="half_rhythm"><div>Behavior problems including aggression [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al 2016</a>]</div></li><li class="half_rhythm"><div>Hyperactivity/hyperkinesia [<a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.sinajon.2016.841">Sinajon et al 2016</a>]</div></li></ul></div></div><div id="christianson.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>To date, no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified.</p></div><div id="christianson.Prevalence"><h3>Prevalence</h3><p>The estimated prevalence of CS is between 1:16,000 and 1:100,000 [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>].</p><p>CS may be among the most common <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> neurodevelopmental disorders based on X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> sequencing of approximately 200 families with suspected X-linked intellectual disability [<a class="bk_pop" href="#christianson.REF.tarpey.2009.535">Tarpey et al 2009</a>].</p></div></div><div id="christianson.Genetically_Related_Allelic"><h2 id="_christianson_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC9A6</i>.</p></div><div id="christianson.Differential_Diagnosis"><h2 id="_christianson_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/angelman/"><b>Angelman syndrome</b></a> (AS) is characterized by severe developmental delay or ID, severe speech impairment, gait ataxia and/or tremulousness of the limbs, and a unique behavioral profile with an inappropriate happy demeanor that includes frequent laughing, smiling, and excitability. Microcephaly and seizures are common. Developmental delays are first noted around age six months; however, the unique clinical features of AS do not become manifest until after age one year, and it can take several years before the correct clinical diagnosis becomes apparent. The diagnosis of AS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets the consensus clinical diagnostic criteria and/or who has findings on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> that suggest deficient expression or function of the maternally inherited <i>UBE3A</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><p>Christianson syndrome (CS) can be clinically distinguished from AS in the following ways:</p><ul><li class="half_rhythm"><div>The presence of progressive cerebellar atrophy in CS [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>], which generally occurs after the first decade of life but can occur before age ten years</div></li><li class="half_rhythm"><div>Lifelong problems with weight gain with a low body mass index in individuals with CS. Those with AS may have poor weight gain in early childhood with later normal weight gain or even obesity in young adulthood.</div></li></ul><p>All genes known to be associated with intellectual disability should be included in the differential diagnosis of Christianson syndrome. More than 180 have been identified; see OMIM Phenotypic Series &#x02013; Intellectual disability:</p><ul><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS156200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Autosomal dominant</a></div></li><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS249500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Autosomal recessive</a></div></li><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS309530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Nonsyndromic, X-linked</a></div></li><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS309510" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">X-linked syndromic</a></div></li></ul></div><div id="christianson.Management"><h2 id="_christianson_Management_">Management</h2><div id="christianson.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Christianson syndrome (CS), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Establishment of baseline neurologic functioning with:</div><ul><li class="half_rhythm"><div>Assessment of adaptive functioning (e.g., Vineland, Bayley Scales of Infant Development)</div></li><li class="half_rhythm"><div>Occupational therapy and physical therapy assessment regarding fine motor and gross motor functioning</div></li><li class="half_rhythm"><div>Speech/language/communication assessment</div></li><li class="half_rhythm"><div>Assessment of behavioral issues, as needed, using such evaluation tools as Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)]</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>EEG</div></li><li class="half_rhythm"><div>Brain MRI (based on the clinician's judgment) to determine if any structural brain abnormalities are present, especially cerebellar / brain stem atrophy</div></li></ul></li><li class="half_rhythm"><div>Evaluation of swallowing function, feeding, and nutrition as needed</div></li><li class="half_rhythm"><div>Ophthalmologic assessment, including evaluation for eye movement abnormalities and visual acuity, when warranted</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="christianson.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="christianson.Developmental_Delay__Intell"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies, and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the United States, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion regarding transition plans and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="christianson.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive functions, such as feeding.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="christianson.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p></div><div id="christianson.Other"><h4>Other</h4><p><b>Seizures.</b> Currently, no guidelines exist for seizure control in Christianson syndrome. A range of antiepileptic drugs has been used, including levetiracetam, valproic acid, clonazepam, clobazam, diazepam, lamotrigine, phenobarbital, oxcarbazepine, carbamazepine, zonisamide, and topiramate [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>].</p><p><b>GI manifestations.</b> Fundoplication has been pursued to treat gastroesophageal reflux disease in some individuals. In a minority, a gastrostomy tube has been placed to improve nutrition. A bowel regimen to prevent constipation is recommended as needed.</p><p><b>Post-hospitalization.</b> Because hospitalization for complications such as pneumonia or epileptic seizures may be particularly high-risk for subsequent regression in psychomotor skills [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>], physical therapy following such an illness may be warranted in some instances.</p></div></div><div id="christianson.Surveillance"><h3>Surveillance</h3><p>At the time of follow-up clinical examinations, the following are recommended:</p><ul><li class="half_rhythm"><div>Measurement of weight and height (and calculation of BMI) because of the increased age-related risk for poor weight gain despite normal or even high caloric intake</div></li><li class="half_rhythm"><div>Assessment for scoliosis/kyphoscoliosis</div></li><li class="half_rhythm"><div>In adolescents / young adults regarding possible regression:</div><ul><li class="half_rhythm"><div>Evaluation for loss of any of the following: feeding skills, fine/gross motor skills, ambulation, use of words/sounds</div></li><li class="half_rhythm"><div>Repeat neuropsychologic assessments (as needed)</div></li><li class="half_rhythm"><div>Assessment using an ataxia rating scale</div></li></ul></li></ul></div><div id="christianson.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#christianson.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="christianson.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="christianson.Genetic_Counseling"><h2 id="_christianson_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="christianson.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Christianson syndrome (CS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="christianson.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have CS nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male, the mother is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. In 40% of families published to date, the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has had a <i>de novo SLC9A6</i> pathogenic variant [<a class="bk_pop" href="#christianson.REF.christianson.1999.759">Christianson et al 1999</a>, <a class="bk_pop" href="#christianson.REF.gilfillan.2008.1003">Gilfillan et al 2008</a>, <a class="bk_pop" href="#christianson.REF.fichou.2009.1378">Fichou et al 2009</a>, <a class="bk_pop" href="#christianson.REF.garbern.2010.1391">Garbern et al 2010</a>, <a class="bk_pop" href="#christianson.REF.schroer.2010.2775">Schroer et al 2010</a>, <a class="bk_pop" href="#christianson.REF.takahashi.2011.799">Takahashi et al 2011</a>, <a class="bk_pop" href="#christianson.REF.tzschach.2011.2771">Tzschach et al 2011</a>, <a class="bk_pop" href="#christianson.REF.riess.2013.596">Riess et al 2013</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.zanni.2014.811">Zanni et al 2014</a>, <a class="bk_pop" href="#christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet et al 2016</a>, <a class="bk_pop" href="#christianson.REF.trump.2016.310">Trump et al 2016</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing of the mother can determine if the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was inherited.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes and may be unaffected or have a range of clinical manifestations (see Clinical Description, <a href="#christianson.Heterozygous_Females_i_e_Ca">Heterozygous Females</a>).</div></li><li class="half_rhythm"><div>If a male represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family), and if the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still less than 1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males with CS are not known to reproduce.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes (carriers) for the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring may be at risk of being carriers or being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose, information that could help determine genetic risk status of the extended family.</p></div><div id="christianson.Heterozygote_Carrier_Detect"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p>Note: Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder may have a range of clinical manifestations (see Clinical Description, <a href="#christianson.Heterozygous_Females_i_e_Ca">Heterozygous Females</a>).</p></div><div id="christianson.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="christianson.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC9A6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="christianson.Resources"><h2 id="_christianson_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Christianson Syndrome Association</b></div><div>15201 Mason Road</div><div>Suite 1000 #173</div><div>Cypress TX 77433</div><div><b>Phone:</b> 281-723-5989</div><div><b>Email:</b> info@csa-cares.org</div><div><a href="http://www.csa-cares.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.csa-cares.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/christianson-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Christianson syndrome</a></div></li><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>EuroMRX Consortium Registry</b></div><div>Radboud University Nijmegen Medical Centre, Department of Human Genetics</div><div>PO Box 9101</div><div>Nijmegen 6500 HB</div><div>Netherlands</div><div><b>Phone:</b> +31 24 3614017</div><div><b>Fax:</b> +31 24 3668752</div><div><b>Email:</b> a.debrouwer@antrg.umcn.nl</div><div><a href="http://www.euromrx.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euromrx.com</a></div></li></ul></div><div id="christianson.Molecular_Genetics"><h2 id="_christianson_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="christianson.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Christianson Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475801/table/christianson.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__christianson.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_christianson.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_christianson.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_christianson.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_christianson.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_christianson.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_christianson.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_christianson.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10479" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC9A6</i></a></td><td headers="hd_b_christianson.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10479" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_christianson.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q92581" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium/hydrogen exchanger 6</a></td><td headers="hd_b_christianson.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/SLC9A6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC9A6 @ LOVD</a></td><td headers="hd_b_christianson.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC9A6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC9A6</a></td><td headers="hd_b_christianson.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC9A6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC9A6</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="christianson.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="christianson.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Christianson Syndrome (<a href="/omim/300231,300243" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK475801/table/christianson.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__christianson.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300231" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300231</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300243" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300243</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH</td></tr></tbody></table></div></div><div id="christianson.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>SLC9A6</i> encodes a Na+/H+ exchanger (NHE). There are nine different NHEs in the mammalian genome. Members of the SLC9 family localize to different membranes in cells where they are thought to influence the pH of luminal areas [<a class="bk_pop" href="#christianson.REF.ohgaki.2011.443">Ohgaki et al 2011</a>].</p><p><b>Gene structure.</b>
<i>SLC9A6</i> is approximately 59 kb; the longest transcript, <a href="/nuccore/NM_001042537.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001042537.1</a> (or <a href="http://www.ensembl.org/Homo_sapiens/Transcript/Summary?g=ENSG00000198689;r=X:135985468-136047264;t=ENST00000370695" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000370695</a>), has 16 coding exons [<a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>]. Alternate <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> results in multiple transcript variants. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK475801/#christianson.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Variants in <i>SLC9A6</i> include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and splice variants and small deletions and insertions. Additionally, three gross deletions have been reported, including a 336-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 and a 314-kb deletion including <i>SLC9A6</i> exons 15-16 and adjacent genes [<a class="bk_pop" href="#christianson.REF.tzschach.2011.2771">Tzschach et al 2011</a>, <a class="bk_pop" href="#christianson.REF.pescosolido.2014.581">Pescosolido et al 2014</a>, <a class="bk_pop" href="#christianson.REF.tzschach.2015.1513">Tzschach et al 2015</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC9A6</i> encodes the 12-membrane spanning sodium-hydrogen exchanger 6 (NHE6) protein, which is composed of 701 amino acids (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_001036002.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001036002.1</a>). The membrane domains encode an exchanger that mediates the electroneutral exchange of sodium for protons. In most cases, the exchanger is thought to mediate the entrance of Na+ into the organelle and to permit the efflux of H+ from intracellular membranes [<a class="bk_pop" href="#christianson.REF.ohgaki.2011.443">Ohgaki et al 2011</a>]. NHE6 is known as an endosomal NHE and has been localized to early, recycling, and late endosomes [<a class="bk_pop" href="#christianson.REF.nakamura.2005.1561">Nakamura et al 2005</a>, <a class="bk_pop" href="#christianson.REF.ouyang.2013.97">Ouyang et al 2013</a>]. NHE6 has been associated with clathrin-dependent transferrin endocytosis [<a class="bk_pop" href="#christianson.REF.xinhan.2011.c1431">Xinhan et al 2011</a>].</p><p>Studies have implicated defects in brain-derived neurotrophic factor (BDNF) endosomal signaling in a mouse model of Christianson syndrome [<a class="bk_pop" href="#christianson.REF.ouyang.2013.97">Ouyang et al 2013</a>]. In general, it appears that one role of NHE6 is to regulate intra-endosomal pH. This process can have multiple roles in protein trafficking and turnover.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gross <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variants clearly result in NHE6 loss of function, which is consistent with the predicted consequences of the majority of other pathogenic variants. Missense and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> variants have been rarely described and may alter protein transport.</p></div></div><div id="christianson.References"><h2 id="_christianson_References_">References</h2><div id="christianson.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.christianson.1999.759">Christianson AL, Stevenson RE, van der Meyden CH, Pelser J, Theron FW, van Rensburg PL, Chandler M, Schwartz CE. X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24-q27. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:759–66.</span> [<a href="/pmc/articles/PMC1734236/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734236</span></a>] [<a href="/pubmed/10528855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10528855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.coorg.2015.527">Coorg R, Weisenberg JL. Successful treatment of electrographic status epilepticus of sleep with felbamate in a patient with SLC9A6 mutation. <span><span class="ref-journal">Pediatr Neurol. </span>2015;<span class="ref-vol">53</span>:527–31.</span> [<a href="/pubmed/26421989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26421989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.fichou.2009.1378">Fichou Y, Bahi-Buisson N, Nectoux J, Chelly J, H&#x000e9;ron D, Cuisset L, Bienvenu T. Mutation in the SLC9A6 gene is not a frequent cause of sporadic Angelman-like syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:1378–80.</span> [<a href="/pmc/articles/PMC2986687/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986687</span></a>] [<a href="/pubmed/19471312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19471312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.garbern.2010.1391">Garbern JY, Neumann M, Trojanowski JQ, Lee VM, Feldman G, Norris JW, Friez MJ, Schwartz CE, Stevenson R, Sima AA. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:1391–402.</span> [<a href="/pmc/articles/PMC2859154/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2859154</span></a>] [<a href="/pubmed/20395263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20395263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.gilfillan.2008.1003">Gilfillan GD, Selmer KK, Roxrud I, Smith R, Kyllerman M, Eiklid K, Kroken M, Mattingsdal M, Egeland T, Stenmark H, Sj&#x000f8;holm H, Server A, Samuelsson L, Christianson A, Tarpey P, Whibley A, Stratton MR, Futreal PA, Teague J, Edkins S, Gecz J, Turner G, Raymond FL, Schwartz C, Stevenson RE, Undlien DE, Str&#x000f8;mme P. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:1003–10.</span> [<a href="/pmc/articles/PMC2427207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427207</span></a>] [<a href="/pubmed/18342287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18342287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.masurelpaulet.2016.2103">Masurel-Paulet A, Piton A, Chancenotte S, Redin C, Thauvin-Robinet C, Henrenger Y, Minot D, Creppy A, Ruffier-Bourdet M, Thevenon J, Kuentz P, Lehalle D, Curie A, Blanchard G, Ghosn E, Bonnet M, Archimbaud-Devilliers M, Huet F, Perret O, Philip N, Mandel JL, Faivre L. A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:2103–10.</span> [<a href="/pubmed/27256868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27256868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.mignot.2013.172">Mignot C, H&#x000e9;ron D, Bursztyn J, Momtchilova M, Mayer M, Whalen S, Legall A, Billette de Villemeur T, Burglen L. Novel mutation in SLC9A6 gene in a patient with Christianson syndrome and retinitis pigmentosum. <span><span class="ref-journal">Brain Dev. </span>2013;<span class="ref-vol">35</span>:172–6.</span> [<a href="/pubmed/22541666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22541666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.nakamura.2005.1561">Nakamura N, Tanaka S, Teko Y, Mitsui K, Kanazawa H. Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:1561–72.</span> [<a href="/pubmed/15522866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15522866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.ohgaki.2011.443">Ohgaki R, van IJzendoorn SC, Matsushita M, Hoekstra D, Kanazawa H. Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. <span><span class="ref-journal">Biochemistry. </span>2011;<span class="ref-vol">50</span>:443–50.</span> [<a href="/pubmed/21171650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21171650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.ouyang.2013.97">Ouyang Q, Lizarraga SB, Schmidt M, Yang U, Gong J, Ellisor D, Kauer JA, Morrow EM. Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. <span><span class="ref-journal">Neuron. </span>2013;<span class="ref-vol">80</span>:97–112.</span> [<a href="/pmc/articles/PMC3830955/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3830955</span></a>] [<a href="/pubmed/24035762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24035762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.pescosolido.2014.581">Pescosolido MF, Stein DM, Schmidt M, El Achkar CM, Sabbagh M, Rogg JM, Tantravahi U, McLean RL, Liu JS, Poduri A, Morrow EM. Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">76</span>:581–93.</span> [<a href="/pmc/articles/PMC4304796/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4304796</span></a>] [<a href="/pubmed/25044251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25044251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.riess.2013.596">Riess A, Rossier E, Kr&#x000fc;ger R, Dufke A, Beck-Woedl S, Horber V, Alber M, Gl&#x000e4;ser D, Riess O, Tzschach A. Novel SLC9A6 mutations in two families with Christianson syndrome. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:596–7.</span> [<a href="/pubmed/22931061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22931061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.schroer.2010.2775">Schroer RJ, Holden KR, Tarpey PS, Matheus MG, Griesemer DA, Friez MJ, Fan JZ, Simensen RJ, Str&#x000f8;mme P, Stevenson RE, Stratton MR, Schwartz CE. Natural history of Christianson syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2775–83.</span> [<a href="/pmc/articles/PMC3698558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3698558</span></a>] [<a href="/pubmed/20949524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.sinajon.2016.841">Sinajon P, Verbaan D, So J. The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature. <span><span class="ref-journal">Hum Genet. </span>2016;<span class="ref-vol">135</span>:841–50.</span> [<a href="/pubmed/27142213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27142213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.takahashi.2011.799">Takahashi Y, Hosoki K, Matsushita M, Funatsuka M, Saito K, Kanazawa H, Goto Y, Saitoh S. A loss-of-function mutation in the SLC9A6 gene causes X-linked mental retardation resembling Angelman syndrome. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2011;<span class="ref-vol">156B</span>:799–807.</span> [<a href="/pubmed/21812100" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21812100</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.tarpey.2009.535">Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, Hardy C, O'Meara S, Latimer C, Dicks E, Menzies A, Stephens P, Blow M, Greenman C, Xue Y, Tyler-Smith C, Thompson D, Gray K, Andrews J, Barthorpe S, Buck G, Cole J, Dunmore R, Jones D, Maddison M, Mironenko T, Turner R, Turrell K, Varian J, West S, Widaa S, Wray P, Teague J, Butler A, Jenkinson A, Jia M, Richardson D, Shepherd R, Wooster R, Tejada MI, Martinez F, Carvill G, Goliath R, de Brouwer AP, van Bokhoven H, Van Esch H, Chelly J, Raynaud M, Ropers HH, Abidi FE, Srivastava AK, Cox J, Luo Y, Mallya U, Moon J, Parnau J, Mohammed S, Tolmie JL, Shoubridge C, Corbett M, Gardner A, Haan E, Rujirabanjerd S, Shaw M, Vandeleur L, Fullston T, Easton DF, Boyle J, Partington M, Hackett A, Field M, Skinner C, Stevenson RE, Bobrow M, Turner G, Schwartz CE, Gecz J, Raymond FL, Futreal PA, Stratton MR. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:535–43.</span> [<a href="/pmc/articles/PMC2872007/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2872007</span></a>] [<a href="/pubmed/19377476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19377476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.trump.2016.310">Trump N, McTague A, Brittain H, Papandreou A, Meyer E, Ngoh A, Palmer R, Morrogh D, Boustred C, Hurst JA, Jenkins L, Kurian MA, Scott RH. Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:310–7.</span> [<a href="/pmc/articles/PMC4862068/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4862068</span></a>] [<a href="/pubmed/26993267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26993267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.tzschach.2011.2771">Tzschach A, Ullmann R, Ahmed A, Martin T, Weber G, Decker-Schwering O, Pauly F, Shamdeen MG, Reith W, Oehl-Jaschkowitz B. Christianson syndrome in a patient with an interstitial Xq26.3 deletion. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2771–4.</span> [<a href="/pubmed/21932316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21932316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.tzschach.2015.1513">Tzschach A, Grasshoff U, Beck-Woedl S, Dufke C, Bauer C, Kehrer M, Evers C, Moog U, Oehl-Jaschkowitz B, Di Donato N, Maiwald R, Jung C, Kuechler A, Schulz S, Meinecke P, Spranger S, Kohlhase J, Seidel J, Reif S, Rieger M, Riess A, Sturm M, Bickmann J, Schroeder C, Dufke A, Riess O, Bauer P. Next-generation sequencing in X-linked intellectual disability. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1513–8.</span> [<a href="/pmc/articles/PMC4613482/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4613482</span></a>] [<a href="/pubmed/25649377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25649377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.xinhan.2011.c1431">Xinhan L, Matsushita M, Numaza M, Taguchi A, Mitsui K, Kanazawa H. Na+/H+ exchanger isoform 6 (NHE6/SLC9A6) is involved in clathrin-dependent endocytosis of transferrin. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2011;<span class="ref-vol">301</span>:C1431–44.</span> [<a href="/pubmed/21881004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21881004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="christianson.REF.zanni.2014.811">Zanni G, Barresi S, Cohen R, Specchio N, Basel-Vanagaite L, Valente EM, Shuper A, Vigevano F, Bertini E. A novel mutation in the endosomal Na+/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES). <span><span class="ref-journal">Epilepsy Res. </span>2014;<span class="ref-vol">108</span>:811–5.</span> [<a href="/pubmed/24630051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24630051</span></a>]</div></li></ul></div></div><div id="christianson.Chapter_Notes"><h2 id="_christianson_Chapter_Notes_">Chapter Notes</h2><div id="christianson.Author_Notes"><h3>Author Notes</h3><p>Dr Eric Morrow's research interests in understanding the genetic and molecular mechanisms of neurodevelopmental disorders, including intellectual disability and autism. His research program has a focus in Christianson syndrome and related neurologic conditions. People interested in learning more about ongoing research studies involving Christianson syndrome may contact him at emorrow@lifespan.org.</p></div><div id="christianson.Acknowledgments"><h3>Acknowledgments</h3><p>We would like to thank the families of individuals diagnosed with Christianson syndrome for their support and participation in research. This work has been supported by the Hassenfeld Child Health Innovation Institute at Brown University, the Angelman Syndrome Foundation general research grant and National Institutes of Health/National Institute of Mental Health grants R01MH105442, R01MH102418, and R21MH115392 (to EMM); and National Institutes of Health/National Institute of Neurological Disorders and Stroke grant F31NS093880 (to MFP).</p></div><div id="christianson.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 January 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>19 January 2015 (emm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK475801</span><span class="label">PMID: <a href="/pubmed/29334451" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29334451</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/choroid/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cgd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK475801&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK475801/?report=reader">PubReader</a></li><li><a href="/books/NBK475801/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK475801" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK475801" style="display:none" title="Cite this Page"><div class="bk_tt">Morrow EM, Pescosolido MF. Christianson Syndrome. 2018 Jan 11. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK475801/pdf/Bookshelf_NBK475801.pdf">PDF version of this page</a> (439K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#christianson.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#christianson.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#christianson.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#christianson.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#christianson.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#christianson.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#christianson.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#christianson.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#christianson.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#christianson.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#christianson.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10479[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC9A6</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4489796" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4489796" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4489796" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4489796" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28211668" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Haack T, Hayflick SJ, Hogarth P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301503" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sloan JL, Carrillo N, Adams D, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29334451" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29334451" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04166439a66ee2ba1a9746">Christianson Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Christianson Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:09:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CDF72E041103100000000024700E6&amp;ncbi_session=CE8CDF72E0416631_0583SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK475801%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK475801&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK475801/&amp;ncbi_pagename=Christianson Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CDF72E0416631_0583SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>